Study to Improve Treatment Adherence in Adults With Eosinophilic Esophagitis Using Education and Reminders

What this Trial Is About

Researchers are evaluating the effects of additional education combined with more frequent follow-up visits and patient reminders on how well adults with eosinophilic esophagitis stick to their long-term treatment plans. This trial focuses on improving treatment adherence, which is often challenging for patients with chronic conditions, including eosinophilic esophagitis. The study is led by the Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA. Participants are randomly assigned to one of two groups one group receives a behavioral intervention that includes extra education, frequent follow-ups, and reminders, while the control group receives no additional intervention. The study is single-blind and monitors treatment adherence over several time points, including 12 weeks, 6 months, and 12 months. During the study, participants will be assessed for treatment adherence using various self-report questionnaires and clinical symptom changes evaluated through specific symptom questionnaires. The primary outcome is treatment adherence at 12 weeks. Secondary outcomes include adherence and symptom changes at 6 and 12 months. Participants involvement includes regular follow-ups and completing questionnaires to track adherence and symptoms throughout the study period, which lasts up to one year.

An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.